Featured Posts
S.127 Would Increase the Deficit by Tens of Billions of Dollars
Today, the Senate Commerce Committee will hold an executive session considering S. 127, the Pharmacy Benefit Manager Transparency Act (PBMTA), legislation that was recently re-introduced by…
Commentary
Biden Budget Expands Disastrous Price Controls on Medicine
President Biden’s Fiscal Year 2024 budget proposal includes an expansion of Democrats’ drug price controls, originally passed in the so-called “Inflation Reduction Act (IRA).”…
Commentary
Sen. Cruz is Right to Urge Caution on Giving FTC New Power to Regulate
Recently, the U.S. Senate Committee on Commerce, Science, and Transportation held a hearing to consider another piece of legislation that would expand the Federal Trade Commission…
Commentary
Filtered Posts
ATR Leads Coalition Opposing Price Controls on Medical Innovation
Letter
Up in Smoke: New Study Highlights Perils of Banning Flavored E-Cigarettes
Commentary
NIH Study: Democrats Vape Tax Would Be A Disaster For Public Health
Commentary
Bloomberg, the World Health Organization & the Vaping Misinfodemic
Commentary
Democrat Bill Imposes Price Controls and 95% Excise Tax on Medical Innovation
Commentary
Ways and Means Republicans Discuss Danger of Dem’s Socialist Drug Price Controls
Commentary
CBO: Dem Healthcare Policies Will Kick Millions of their Healthcare Plans, Increase Deficit
Commentary
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Norquist Warns of Dem Drug Price Controls, New IRS Reporting Regime
Commentary
Study: Democrats’ $3.5 Trillion Bill Will Lead to Up To 324 Fewer New Medicines
Commentary